First Time Loading...

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 4.76 USD -4.03% Market Closed
Updated: Apr 19, 2024

ROA
Return on Assets

-54.3%
Current
-45%
Average
-31.5%
Industry
Negative for the last year
-54.3%
Negative average
-45%
Worse than average
Worse than industry value

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-54.3%
=
Net Income
-240.1m
/
Total Assets
411.2m

ROA Across Competitors

ROA Comparison
ADC Therapeutics SA Competitors

Country CH
Market Cap 392.8m USD
ROA
-54%
Country US
Market Cap 293.2B USD
ROA
4%
Country US
Market Cap 141.2B USD
ROA
8%
Country US
Market Cap 101.4B USD
ROA
18%
Country US
Market Cap 98.2B USD
ROA
13%
Country AU
Market Cap 131.7B AUD
ROA
7%
Country US
Market Cap 82.3B USD
ROA
9%
Country US
Market Cap 43.1B USD
ROA
-21%
Country US
Market Cap 39.2B USD
ROA
-21%
Country US
Market Cap 27.6B USD
ROA
5%
Country IE
Market Cap 26.6B USD
ROA
5%

Profitability Report

View the profitability report to see the full profitability analysis for ADC Therapeutics SA.

See Also

Discover More
What is Return on Assets?

ROA, or Return on Assets, is an indicator of how well a company utilizes its assets in terms of profitability. This number tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. A higher ROA indicates more efficient use of assets to produce earnings, making it a valuable gauge for investors assessing a company's operational efficiency and profitability potential.

ROA
-54.3%
=
Net Income
-240.1m
/
Total Assets
411.2m
What is the ROA of ADC Therapeutics SA?

Based on ADC Therapeutics SA's most recent financial statements, the company has ROA of -54.3%.